It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Genome-wide association studies (GWAS) have identified more than 200 common genetic variants independently associated with colorectal cancer (CRC) risk, but the causal variants and target genes are mostly unknown. We sought to fine-map all known CRC risk loci using GWAS data from 100,204 cases and 154,587 controls of East Asian and European ancestry. Our stepwise conditional analyses revealed 238 independent association signals of CRC risk, each with a set of credible causal variants (CCVs), of which 28 signals had a single CCV. Our cis-eQTL/mQTL and colocalization analyses using colorectal tissue-specific transcriptome and methylome data separately from 1299 and 321 individuals, along with functional genomic investigation, uncovered 136 putative CRC susceptibility genes, including 56 genes not previously reported. Analyses of single-cell RNA-seq data from colorectal tissues revealed 17 putative CRC susceptibility genes with distinct expression patterns in specific cell types. Analyses of whole exome sequencing data provided additional support for several target genes identified in this study as CRC susceptibility genes. Enrichment analyses of the 136 genes uncover pathways not previously linked to CRC risk. Our study substantially expanded association signals for CRC and provided additional insight into the biological mechanisms underlying CRC development.
Here, the authors perform large trans-ancestry fine-mapping analyses identifying large numbers of association signals and putative target genes for colorectal cancer risk, advancing our understanding of the genetic and biological basis of this cancer.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










































































































1 Vanderbilt University Medical Center, Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
2 Vanderbilt University Medical Center, Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University School of Medicine, Department of Biomedical Informatics, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217)
3 Vanderbilt University Medical Center, Department of Biostatistics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916); Vanderbilt University Medical Center, Vanderbilt Genetics Institute, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
4 Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622)
5 Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK (GRID:grid.18886.3f) (ISNI:0000 0001 1499 0189)
6 University of Edinburgh, Edinburgh Cancer Research Centre, Institute of Genomics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); Instituto de Investigacion Sanitaria de Santiago, Genomic Medicine Group, Santiago de Compostela, Spain (GRID:grid.488911.d) (ISNI:0000 0004 0408 4897)
7 Vanderbilt University Medical Center, Department of Biostatistics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
8 Yale School of Public Health, Department of Biostatistics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
9 University of Edinburgh, Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); University of Southern Denmark, Danish Institute for Advanced Study, Department of Public Health, Odense, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
10 Cleveland Clinic, Genomic Medicine Institute, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); Case Comprehensive Cancer Center, Population and Cancer Prevention Program, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0004 0455 2742)
11 Bellvitge Biomedical Research Institute, Colorectal Cancer Group, ONCOBELL Program, Barcelona, Spain (GRID:grid.418284.3) (ISNI:0000 0004 0427 2257); Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain (GRID:grid.466571.7) (ISNI:0000 0004 1756 6246); University of Barcelona, Department of Clinical Sciences, Faculty of Medicine, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247); Catalan Institute of Oncology, Oncology Data Analytics Program, Barcelona, Spain (GRID:grid.418701.b) (ISNI:0000 0001 2097 8389)
12 University of Virginia, Center for Public Health Genomics, Department of Public Health Sciences, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
13 University of Edinburgh, Edinburgh Cancer Research Centre, Institute of Genomics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
14 University of Birmingham, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
15 University of Oxford, Department of Public Health, Richard Doll Building, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
16 University of Edinburgh, Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
17 University of Southern California, Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
18 Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847); Case Western Reserve University, Department of Population and Quantitative Health Sciences, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
19 Nationwide Children’s Hospital, The Steve and Cindy Rasmussen Institute for Genomic Medicine, Columbus, USA (GRID:grid.240344.5) (ISNI:0000 0004 0392 3476)
20 Clalit National Cancer Control Center, Haifa, Israel (GRID:grid.413469.d); Lady Davis Carmel Medical Center, Department of Community Medicine and Epidemiology, Haifa, Israel (GRID:grid.471000.2); Technion-Israel Institute of Technology, Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000 0001 2110 2151)
21 Bellvitge Biomedical Research Institute, Colorectal Cancer Group, ONCOBELL Program, Barcelona, Spain (GRID:grid.418284.3) (ISNI:0000 0004 0427 2257); Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain (GRID:grid.466571.7) (ISNI:0000 0004 1756 6246); Catalan Institute of Oncology, Oncology Data Analytics Program, Barcelona, Spain (GRID:grid.418701.b) (ISNI:0000 0001 2097 8389)
22 Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain (GRID:grid.466571.7) (ISNI:0000 0004 1756 6246); University of León, Biomedicine Institute, León, Spain (GRID:grid.4807.b) (ISNI:0000 0001 2187 3167)
23 National Cancer Center, Center for Colorectal Cancer, National Cancer Center Hospital, Gyeonggi-do, South Korea (GRID:grid.410914.9) (ISNI:0000 0004 0628 9810)
24 National Cancer Center, Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, Gyeonggi-do, South Korea (GRID:grid.410914.9) (ISNI:0000 0004 0628 9810)
25 Yonsei University, Department of Epidemiology and Health Promotion, Graduate School of Public Health, Seoul, South Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
26 Chonnam National University Medical School, Department of Preventive Medicine, Gwangju, South Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399)
27 Seoul National University, Cancer Research Institute, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University College of Medicine, Department of Preventive Medicine, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
28 Seoul National University College of Medicine, Department of Preventive Medicine, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
29 Hallym University College of Medicine, Department of Social and Preventive Medicine, Okcheon-dong, South Korea (GRID:grid.256753.0) (ISNI:0000 0004 0470 5964)
30 Aichi Cancer Center Research Institute, Division of Cancer Epidemiology and Prevention, Nagoya, Japan (GRID:grid.410800.d) (ISNI:0000 0001 0722 8444)
31 Nagoya University Graduate School of Medicine, Department of Epidemiology, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X); Aichi Cancer Center Research Institute, Division of Molecular and Clinical Epidemiology, Nagoya, Japan (GRID:grid.410800.d) (ISNI:0000 0001 0722 8444)
32 University of Tokyo, Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2169 1048)
33 University of Tokyo, Laboratory of Genome Technology, Human Genome Center, Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
34 Sun Yat-sen University, School of Public Health, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X)
35 Shanghai Jiaotong University School of Medicine, State Key Laboratory of Oncogenes and Related Genes and Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)
36 Sun Yat-sen University, State Key Laboratory of Oncology in South China, Cancer Center, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X)
37 University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Seoul National University, Department of Epidemiology, School of Public Health and Institute of Health and Environment, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
38 University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
39 Mayo Clinic Arizona, Department of Laboratory Medicine and Pathology, Scottsdale, USA (GRID:grid.417468.8) (ISNI:0000 0000 8875 6339)
40 University of Southern California, Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853); Cedars-Sinai Medical Center, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
41 Cedars-Sinai Cancer Research Center for Health Equity, Division of Oncology, Department of Medicine, Los Angeles, USA (GRID:grid.50956.3f)
42 University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
43 Memorial University of Newfoundland, Division of Biomedical Sciences, St. John, Canada (GRID:grid.25055.37) (ISNI:0000 0000 9130 6822)
44 Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, School of Public Health, Seattle, USA (GRID:grid.34477.33) (ISNI:0000 0001 2298 6657)
45 Translational Genomics Research Institute, City of Hope National Medical Center, Phoenix, USA (GRID:grid.250942.8) (ISNI:0000 0004 0507 3225)
46 Cardiff University, Institute of Medical Genetics, Cardiff, UK (GRID:grid.5600.3) (ISNI:0000 0001 0807 5670)
47 Medical Research Council, MRC Clinical Trials Unit, Cardiff, UK (GRID:grid.14105.31) (ISNI:0000000122478951)
48 University of Oxford, Department of Oncology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
49 University of Oxford, Radcliffe Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
50 Sestre milosrdnice University Hospital Center, Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia (GRID:grid.412488.3) (ISNI:0000 0000 9336 4196)
51 Central Finland Health Care District, Department of Pathology, Jyväskylä, Finland (GRID:grid.460356.2) (ISNI:0000 0004 0449 0385)
52 Central Finland Health Care District, Jyväskylä, Finland (GRID:grid.460356.2) (ISNI:0000 0004 0449 0385)
53 Finnish Institute for Health and Welfare, Department of Health and Welfare, Helsinki, Finland (GRID:grid.14758.3f) (ISNI:0000 0001 1013 0499)
54 University of Helsinki, Department of Medical and Clinical Genetics, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); University of Helsinki, Genome-Scale Biology Research Program, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
55 Finnish Institute for Health and Welfare, Department of Public Health and Welfare, Helsinki, Finland (GRID:grid.14758.3f) (ISNI:0000 0001 1013 0499)
56 Tampere University, Faculty of Social Sciences, Tampere, Finland (GRID:grid.502801.e) (ISNI:0000 0001 2314 6254); Institute for Statistical and Epidemiological Cancer Research, Finnish Cancer Registry, Helsinki, Finland (GRID:grid.424339.b) (ISNI:0000 0000 8634 0612)
57 University of Helsinki, Folkhälsan Research Centre, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); National University of Singapore, Human Potential Translational Research Programme, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); University of Helsinki and Helsinki University Hospital, Unit of General Practice and Primary Health Care, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
58 Helsinki University Hospital, Department of Surgery, Abdominal Centre, Helsinki, Finland (GRID:grid.15485.3d) (ISNI:0000 0000 9950 5666)
59 National Institutes of Health, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
60 University of Michigan, Department of Nutritional Sciences, School of Public Health, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000 0004 1936 7347)
61 Boston University School of Medicine, Department of Medicine, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558); Slone Epidemiology Center at Boston University, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558)
62 University of Melbourne, Colorectal Oncogenomics Group, Department of Clinical Pathology, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Royal Melbourne Hospital, Genomic Medicine and Family Cancer Clinic, Parkville, Australia (GRID:grid.416153.4) (ISNI:0000 0004 0624 1200); Victorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Parkville, Australia (GRID:grid.431578.c) (ISNI:0000 0004 5939 3689)
63 Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311)
64 University of Utah, Huntsman Cancer Institute and Department of Population Health Sciences, Salt Lake City, USA (GRID:grid.223827.e) (ISNI:0000 0001 2193 0096)
65 H. Lee Moffitt Cancer Center and Research Institute, Cancer Epidemiology Program, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233)
66 Medical University Vienna, Institute of Cancer Research, Department of Medicine I, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)
67 Albert Einstein College of Medicine, Department of Epidemiology and Population Health, New York, USA (GRID:grid.251993.5) (ISNI:0000 0001 2179 1997)
68 German Cancer Research Center, Division of Cancer Epidemiology, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); University Cancer Centre Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany (GRID:grid.412315.0)
69 German Cancer Research Center, Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584)
70 German Cancer Research Center, Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); German Cancer Research Center and National Center for Tumor Diseases, Division of Preventive Oncology, Heidelberg, Germany (GRID:grid.461742.2) (ISNI:0000 0000 8855 0365); German Cancer Research Center, German Cancer Consortium, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584)
71 University of Utah, Department of Internal Medicine, Salt Lake City, USA (GRID:grid.223827.e) (ISNI:0000 0001 2193 0096)
72 Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); Massey University, Research Centre for Hauora and Health, Wellington, New Zealand (GRID:grid.148374.d) (ISNI:0000 0001 0696 9806)
73 Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); University of Ioannina School of Medicine, Department of Hygiene and Epidemiology, Ioannina, Greece (GRID:grid.9594.1) (ISNI:0000 0001 2108 7481)
74 German Institute of Human Nutrition Potsdam-Rehbruecke, Department of Molecular Epidemiology, Nuthetal, Germany (GRID:grid.418213.d) (ISNI:0000 0004 0390 0098); University of Potsdam, Institute of Nutritional Science, Potsdam, Germany (GRID:grid.11348.3f) (ISNI:0000 0001 0942 1117)
75 World Health Organization, Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France (GRID:grid.17703.32) (ISNI:0000 0004 0598 0095)
76 University of Barcelona, Gastroenterology Department, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247)
77 Stanford University, Department of Genetics, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
78 University of Leeds, Leeds Institute of Medical Research at St James’s, Leeds, UK (GRID:grid.9909.9) (ISNI:0000 0004 1936 8403)
79 University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, Australia (GRID:grid.3263.4) (ISNI:0000 0001 1482 3639); Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
80 Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, Australia (GRID:grid.3263.4) (ISNI:0000 0001 1482 3639); Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); University of Melbourne, Department of Clinical Pathology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
81 City of Hope National Medical Center, Department of Medical Oncology and Center For Precision Medicine, Duarte, USA (GRID:grid.410425.6) (ISNI:0000 0004 0421 8357)
82 Clalit National Cancer Control Center, Haifa, Israel (GRID:grid.413469.d); Technion-Israel Institute of Technology, Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000 0001 2110 2151); City of Hope National Medical Center, Department of Medical Oncology and Center For Precision Medicine, Duarte, USA (GRID:grid.410425.6) (ISNI:0000 0004 0421 8357)
83 Lady Davis Carmel Medical Center, Department of Community Medicine and Epidemiology, Haifa, Israel (GRID:grid.471000.2)
84 Clalit National Cancer Control Center, Haifa, Israel (GRID:grid.413469.d); Technion-Israel Institute of Technology, Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000 0001 2110 2151); University of Michigan, Department of Pathology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000 0004 1936 7347)
85 Clalit National Cancer Control Center, Haifa, Israel (GRID:grid.413469.d); Lady Davis Carmel Medical Center, Department of Community Medicine and Epidemiology, Haifa, Israel (GRID:grid.471000.2); Lady Davis Carmel Medical Center, Clalit Health Services, Personalized Genomic Service, Haifa, Israel (GRID:grid.414553.2) (ISNI:0000 0004 0575 3597)
86 Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Weill Cornell Medical College, Department of Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
87 Kaiser Permanente Washington Health Research Institute, Seattle, USA (GRID:grid.488833.c) (ISNI:0000 0004 0615 7519)
88 University of North Carolina, Center for Gastrointestinal Biology and Disease, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)
89 Umeå University, Department of Radiation Sciences, Oncology Unit, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451); Umeå University, Wallenberg Centre for Molecular Medicine, Umeå, Sweden (GRID:grid.12650.30) (ISNI:0000 0001 1034 3451)
90 Ontario Institute for Cancer Research, Toronto, Canada (GRID:grid.419890.d) (ISNI:0000 0004 0626 690X)
91 Ohio State University Comprehensive Cancer Center, Division of Human Genetics, Department of Internal Medicine, Columbus, USA (GRID:grid.413944.f) (ISNI:0000 0001 0447 4797)
92 New York University School of Medicine, Division of Epidemiology, Department of Population Health, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)
93 University of California San Diego, Department of Family Medicine and Public Health, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242); University of California San Diego Moores Cancer Center, Population Sciences, Disparities and Community Engagement, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0004 0412 5492)
94 Fred Hutchinson Cancer Center, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622)
95 University of Cambridge, Department of Public Health and Primary Care, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)
96 Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
97 Taipei Medical University, Taipei, Taiwan (GRID:grid.412896.0) (ISNI:0000 0000 9337 0481)
98 University of Southern California, Department of Medicine, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
99 Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington School of Public Health, Department of Epidemiology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
100 Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
101 Johns Hopkins University School of Medicine, Center for Inherited Disease Research, Department of Genetic Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311)
102 Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Brigham and Women’s Hospital and Harvard Medical School, Channing Division of Network Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); Massachusetts General Hospital and Harvard Medical School, Clinical and Translational Epidemiology Unit, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard University, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X); Harvard University, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X); Massachusetts General Hospital and Harvard Medical School, Division of Gastroenterology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
103 University of Puerto Rico, Comprehensive Cancer Center, San Juan, Puerto Rico (GRID:grid.32224.35) (ISNI:0000 0004 0373 6857)
104 Karolinska University Hospital, Department of Clinical Genetics, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705); Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
105 Harvard University, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X); University of Oxford, Nuffield Department of Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
106 Massachusetts General Hospital and Harvard Medical School, Clinical and Translational Epidemiology Unit, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard University, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X)
107 University Hospital Rostock, Department of General Surgery, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454)
108 Case Western Reserve University, Department of Genetics and Genome Sciences, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
109 Stanford University, Department of Genetics, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University, Department of Computer Science, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956)
110 University of Pittsburgh Medical Center, Department of Medicine and Epidemiology, Pittsburgh, USA (GRID:grid.412689.0) (ISNI:0000 0001 0650 7433)
111 Technische Universität Dresden, Department of Medicine I, University Hospital Dresden, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257)
112 Weill Cornell Medical College, Department of Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Memorial Sloan-Kettering Cancer Center, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
113 Institute of Experimental Medicine of the Czech Academy of Sciences, Department of Molecular Biology of Cancer, Prague, Czech Republic (GRID:grid.424967.a) (ISNI:0000 0004 0404 6946); Charles University, Faculty of Medicine and Biomedical Center in Pilsen, Pilsen, Czech Republic (GRID:grid.4491.8) (ISNI:0000 0004 1937 116X); Charles University, Institute of Biology and Medical Genetics, First Faculty of Medicine, Prague, Czech Republic (GRID:grid.4491.8) (ISNI:0000 0004 1937 116X)
114 University of Tennessee Health Science Center, Department of Surgery, Memphis, USA (GRID:grid.267301.1) (ISNI:0000 0004 0386 9246)
115 Ohio State University, Departments of Cancer Biology and Genetics and Internal Medicine, Comprehensive Cancer Center, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
116 Case Western Reserve University and University Hospitals of Cleveland, Departments of Medicine and Genetics, Case Comprehensive Cancer Center, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
117 Wageningen University and Research, Division of Human Nutrition and Health, Wageningen, The Netherlands (GRID:grid.4818.5) (ISNI:0000 0001 0791 5666)
118 Wageningen University and Research, Division of Human Nutrition, Wageningen, The Netherlands (GRID:grid.4818.5) (ISNI:0000 0001 0791 5666)
119 Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); Kaiser Permanente Northern California, Division of Research, Oakland, USA (GRID:grid.280062.e) (ISNI:0000 0000 9957 7758)
120 Servicio Galego de Saude, Genomic Medicine Group, Galician Public Foundation of Genomic Medicine, Santiago de Compostela, Spain (GRID:grid.443929.1) (ISNI:0000 0004 4688 8850); Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain (GRID:grid.488911.d) (ISNI:0000 0004 0408 4897)
121 Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy (GRID:grid.419555.9) (ISNI:0000 0004 1759 7675); Candiolo Cancer Institute FPO-IRCCS, Italian Institute for Genomic Medicine, Candiolo, Italy (GRID:grid.428948.b) (ISNI:0000 0004 1784 6598)
122 Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, Australia (GRID:grid.3263.4) (ISNI:0000 0001 1482 3639); University of Tasmania, Menzies Institute for Medical Research, Hobart, Australia (GRID:grid.1009.8) (ISNI:0000 0004 1936 826X)
123 National University of Singapore, National University Cancer Institute, Singapore, Cancer Science Institute of Singapore, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
124 Harvard University, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X); Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Dana-Farber Harvard Cancer Center, Cancer Immunology Program, Boston, USA (GRID:grid.477947.e) (ISNI:0000 0004 5902 1762); Harvard Medical School, Department of Pathology, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
125 Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Biostatistics, Seattle, USA (GRID:grid.34477.33) (ISNI:0000 0001 2298 6657)
126 Centre Hospitalier Universitaire Nantes, Service de Génétique Médicale, Nantes, France (GRID:grid.277151.7) (ISNI:0000 0004 0472 0371)
127 National Cancer Center, Division of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan (GRID:grid.272242.3) (ISNI:0000 0001 2168 5385)
128 National Cancer Center, Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan (GRID:grid.272242.3) (ISNI:0000 0001 2168 5385)
129 National Cancer Center, Division of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan (GRID:grid.272242.3) (ISNI:0000 0001 2168 5385); National Cancer Center, Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan (GRID:grid.272242.3) (ISNI:0000 0001 2168 5385)
130 University of Hawaii, Cancer Center, Honolulu, USA (GRID:grid.410445.0) (ISNI:0000 0001 2188 0957)
131 University of Southern California, Preventative Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
132 University of Southern California, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
133 Van Andel Research Institute, Grand Rapids, USA (GRID:grid.251017.0) (ISNI:0000 0004 0406 2057)
134 University of Edinburgh, MRC Human Genetics Unit, Institute of Genomics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
135 University of Edinburgh, Lothian Birth Cohorts group, Department of Psychology, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
136 University of Edinburgh, Centre for Global Health, Usher Institute, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
137 University of Edinburgh, Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); National University Health System, Department of Pathology, National University Hospital, Singapore, Singapore (GRID:grid.410759.e) (ISNI:0000 0004 0451 6143)
138 Vanderbilt University School of Medicine, Epithelial Biology Center and Department of Cell and Developmental Biology, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217)
139 Yale School of Public Health, Department of Biostatistics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale School of Medicine, Department of Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Program in Computational Biology and Bioinformatics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710)
140 Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Biostatistics, School of Public Health, Seattle, USA (GRID:grid.34477.33) (ISNI:0000 0001 2298 6657)
141 Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, USA (GRID:grid.270240.3) (ISNI:0000 0001 2180 1622); University of Washington, Department of Epidemiology, Seattle, USA (GRID:grid.34477.33) (ISNI:0000 0001 2298 6657)
142 University of Edinburgh, Edinburgh Cancer Research Centre, Institute of Genomics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); University of Birmingham, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)